Evoke plc (LON:EVOK – Get Free Report)’s share price dropped 10% during mid-day trading on Thursday . The company traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). Approximately 65,066,164 shares traded hands during trading, an increase of 1,994% from the average daily volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Analyst Upgrades and Downgrades
Several research analysts have recently issued reports on EVOK shares. Jefferies Financial Group reaffirmed a “buy” rating and issued a GBX 140 ($1.81) target price on shares of Evoke in a research note on Monday, December 16th. Berenberg Bank reduced their price objective on shares of Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating on the stock in a research note on Wednesday, December 4th.
View Our Latest Report on Evoke
Evoke Stock Down 1.1 %
Evoke (LON:EVOK – Get Free Report) last announced its quarterly earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) EPS for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. On average, sell-side analysts expect that Evoke plc will post 12.7648305 EPS for the current fiscal year.
Insider Buying and Selling at Evoke
In other Evoke news, insider Andrea Gisle Joosen acquired 14,572 shares of the business’s stock in a transaction dated Tuesday, January 28th. The shares were acquired at an average price of GBX 70 ($0.91) per share, for a total transaction of £10,200.40 ($13,202.69). Insiders own 27.00% of the company’s stock.
Evoke Company Profile
Read More
- Five stocks we like better than Evoke
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- MarketBeat Week in Review – 03/24 – 03/28
- What to Know About Investing in Penny Stocks
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Financial Services Stocks Investing
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.